ANDROMEDA: Dara-VCd for newly diagnosed AL amyloidosis: the next galaxy or a new standard of care?
Expert Opin Biol Ther
.
2022 Apr;22(4):445-447.
doi: 10.1080/14712598.2022.2035357.
Epub 2022 Feb 2.
Authors
James A Davis
1
,
Hamza Hashmi
2
Affiliations
1
MUSC College of Pharmacy, Malignant Hematology, Medical University of South Carolina, MUSC Hollings Cancer Center, Charleston29425.
2
Hematology/Oncology, Division of Malignant Hematology and Bone Marrow Transplant, Medical University of South Carolina, Charleston.
PMID:
35084284
DOI:
10.1080/14712598.2022.2035357
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Combined Chemotherapy Protocols
Humans
Immunoglobulin Light-chain Amyloidosis* / diagnosis
Immunoglobulin Light-chain Amyloidosis* / drug therapy
Multiple Myeloma* / drug therapy
Standard of Care